Ramon Güimil García
Technik-/Wissenschafts-/F&E-Leiter bei Hummingbird Diagnostics GmbH
Profil
Ramon Güimil García is currently working as Vice President-Research & Development at Hummingbird Diagnostics GmbH.
Prior to this, he worked as Principal at The European Molecular Biology Laboratory and Nucleic Acid Synthesis Group.
Aktive Positionen von Ramon Güimil García
| Unternehmen | Position | Beginn |
|---|---|---|
Hummingbird Diagnostics GmbH
 Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Technik-/Wissenschafts-/F&E-Leiter | 30.11.2009 |
Ehemalige bekannte Positionen von Ramon Güimil García
| Unternehmen | Position | Ende |
|---|---|---|
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - |
| Nucleic Acid Synthesis Group | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Health Technology |
| Nucleic Acid Synthesis Group |
